Tbilisi, Georgia. February 21, 2017. On February 17, 2017 the State Regulation Agency for Medical Activities, Ministry of Labour, Health and Social Affairs of Georgia granted Cromos™ Pharma approval to conduct the very first ophthalmology trial in Georgia. This international Phase III study in patients with Dry Eye Disease will enroll patients at 3 specialized ophthalmological centers.
As it has always been the case in Georgia the study approval process surpassed all expectations and took only 3 weeks after the dossier was submitted.
"Georgia has emerged as a very fruitful country for clinical research", said Tsira Jibladze, head of Georgia office of Cromos™ Pharma. "We are proud to spearhead the first ophthalmology study in Georgia and to lead the way to opening this new field of clinical research".
About Cromos™ Pharma
Cromos™ Pharma, LLC is a contract research organization (CRO) with operations in the post-Soviet space and in Eastern/Central Europe. The company provides a full spectrum of trial-related services which include clinical monitoring, regulatory approvals, medical writing, feasibility assessments, project management and warehousing. Cromos™ Pharma, LLC is a privately owned company.